Ajinomoto: Notice of Cancellation of Treasury Shares

TOKYO , August 29, 2023 (press release) –

Ajinomoto Co. announced the resolution made at a meeting of its board of directors held on August 29, 2023 to cancel treasury shares pursuant to Article 178 of the Companies Act. The number of shares to be cancelled is 8,367,300 shares excluding 1,324,500 shares, which is 0.25% of the total number of issued shares held as treasury shares.

Original Press Release:

TOKYO, Aug. 29 -- Ajinomoto issued the following news release:

- (Cancellation of treasury shares pursuant to the provisions of Article 178 of the Companies Act)

Ajinomoto Co., Inc. (“Ajinomoto Co.”) announced the resolution made at a meeting of its board of directors held on August 29, 2023 to cancel treasury shares pursuant to Article 178 of the Companies Act, as outlined below.

The number of shares to be cancelled is 8,367,300 shares excluding 1,324,500 shares, which is 0.25% of the total number of issued shares held as treasury shares, out of the 9,691,800 shares purchased through OffAuction Own Share Repurchase Trading (ToSTNeT-3) and in the market through the Tokyo Stock Exchange between May 12th and July 31st, 2023 .

Disclaimer: Table can be viewed at: https://www.ajinomoto.com/cms_wp_ajnmt_global/wp-content/uploads/pdf/2023_08_29E-1.pdf

The Ajinomoto Group will contribute to the well-being of all human beings, our society and our planet with “AminoScience” based on the corporate slogan “Eat Well, Live Well.”. The Ajinomoto Group has offices in 36 countries and regions, and sells products in more than 130 countries and regions. In fiscal 2022, sales were 1.3591 trillion yen ( 10.0 billion U.S. dollars ). To learn more, visit www.ajinomoto.com.

Source: Ajinomoto

[Category: Financial/ Capital Market, Funding Activities]

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.